J&J MedTech Reports First Patient Enrollment in FORWARD CAD trial of Shockwave Javelin Coronary IVL Catheter
Shots:
- Shockwave Medical (J&J MedTech’s company) has initiated the pivotal FORWARD CAD IDE trial with first pts enrolled, evaluating safety & efficacy of the Shockwave Javelin coronary IVL catheter to treat calcified, hard-to-cross de novo coronary artery lesions prior to stenting
- Trial will evaluate the coronary IVL catheter in ~158 pts with mod. to sev. calcified, stenotic de novo coronary lesions, presenting with stable angina or post-ACS stabilization, & eligible for non-emergent PCI at 35 sites in the US & UK
- Shockwave Javelin includes a single distal emitter that produces ultrasonic shockwaves, with each shockwave creating spherical energy field to allow lithotripsy closer to calcium than balloon-based platforms
Ref: J&J | Image: J&J MedTech
Related News:- J&J MedTech Reports the US FDA‘s 510(k) Clearance of MONARCH QUEST for Robot-Assisted Bronchoscopy
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
